Find Academic Supervisors

Professor Maria Craig is a distinguished academic and researcher at the University of New South Wales, Faculty of Medicine & Health, specializing in childhood diabetes research. She holds a prominent position as a Professor with extensive contributions to the field of pediatric endocrinology and diabetes, particularly focusing on type 1 diabetes in children. Professor Craig's educational background includes: MB BS from the University of Melbourne MMedSc(ClinEpid) from the University of Newcastle PhD from the University of Sydney FRACP (Fellow of the Royal Australasian College of Physicians) Professor Craig's research primarily focuses on childhood diabetes, with special emphasis on prediction and prevention of type 1 diabetes. She has a significant interest in the association between viruses and type 1 diabetes, collaborating with the Virology Research Group at Prince of Wales Hospital (POWH). Together with Professor Bill Rawlinson, she leads the viral theme for the multicentre ENDIA study (endia.org.au). As principal investigator for the CoRD trial, she is conducting a world-first phase 1 study using autologous cord blood for prevention of type 1 diabetes in children with islet autoimmunity. Additionally, she serves as principal investigator for the Australasian Diabetes Data Network (ADDN). Her research portfolio also encompasses the epidemiology of various forms of childhood diabetes (type 1, type 2, cystic fibrosis related diabetes and monogenic diabetes) and diabetes complications, in collaboration with Professor Kim Donaghue at the Children's Hospital at Westmead. Professor Craig's extensive publication record, including over 361 journal articles, demonstrates her leadership in advancing our understanding of childhood diabetes. Her recent work shows increasing focus on early detection methods, risk prediction models, technological interventions for diabetes management, and the complex interplay between viral infections and autoimmune diabetes development. She has been instrumental in developing clinical practice guidelines through her role as co-editor of the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Professor Craig has received numerous prestigious awards recognizing her contributions to pediatric endocrinology and diabetes research: Australian Paediatric Endocrine Group Young Investigator's Award (1997) Asia Pacific Paediatric Endocrine Society Clinical Teaching Award (2008) Lifetime Honorary Member, Caring and Living as Neighbours (2013) Australian Diabetes Society Jeff Flack Diabetes Data Award (2019) Australian Paediatric Endocrine Group Norman Wettenhall Award for Research and Innovation (2019) Throughout her career, Professor Craig has demonstrated exceptional leadership in professional societies, having served as former president/treasurer of the Australasian Paediatric Endocrine Group (APEG) and currently as Scientific Convenor of the Asia Pacific Paediatric Endocrine Society Fellows school. Her work with the ENDIA study and Australasian Diabetes Data Network represents significant collaborative research efforts involving multiple institutions across Australia and internationally. Her principal investigator roles for major studies indicate substantial research funding support. Professor Craig leads several important research initiatives including the ENDIA study, the CoRD trial, and the Australasian Diabetes Data Network. These programs involve multidisciplinary teams of researchers, clinicians, and support staff working collaboratively to advance understanding and treatment of childhood diabetes. Her work at the intersection of virology and diabetes represents a unique and innovative approach to understanding the environmental triggers of type 1 diabetes.

• Childhood Diabetes
• Type 1 Diabetes
• Virology and Diabetes
• +4 more

Dr. Keith Alexander Sharkey is a Professor in the Department of Physiology and Pharmacology at the Cumming School of Medicine, University of Calgary. He is also a Full Member of both the Hotchkiss Brain Institute and The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases. Dr. Sharkey has been at the University of Calgary since his appointment as Assistant Professor in 1990, dedicating his career to understanding the neural control of the gastrointestinal tract. From 2005-2021, he held the Crohn's and Colitis Canada Chair in Inflammatory Bowel Disease Research, demonstrating his longstanding commitment to advancing knowledge in gastrointestinal sciences. Dr. Sharkey's educational journey began with a BSc (Hons) in Nutrition from the University of London in 1981, followed by a PhD in Physiology from the University of Liverpool in 1985. After completing postdoctoral training in Hungary, the UK, and Canada, he joined the University of Calgary faculty in 1990, where he has remained throughout his distinguished academic career. Dr. Sharkey's research program centers on understanding the physiology and pathophysiology of the neural control of the gastrointestinal tract and brain-gut interactions in health and disease. His laboratory investigates two main areas: the role of the endocannabinoid system in regulating GI motility and intestinal barrier function, and the physiology of the enteric nervous system in controlling motility and barrier function. His work employs state-of-the-art approaches including live cell imaging and molecular genetics. Recent publications show his expanding interest in connections between gut function and neurodegenerative conditions like ALS, with multiple 2024-2025 papers examining sexual dimorphism in disease processes and gut-brain axis mechanisms. Fellow, Royal Society of Canada (2024) Cumming School of Medicine's van de Sande Distinguished Achievement Award for Mentorship (2021) Distinguished Research Award, American Physiological Society (2021) Finkelstein Award for Excellence, Crohn's and Colitis Canada (2016) Fellow, Canadian Academy of Health Sciences (2015) Fellow, Canadian Association of Gastroenterology (2015) Killam Annual Professor Award, University of Calgary (2013) Dr. Sharkey has mentored numerous students throughout his career, as evidenced by his 2021 Mentorship Award. His research is supported by significant funding, including a CIHR Foundation grant exploring how enteric nerves and glia maintain intestinal homeostasis. He has also participated in university strategic initiatives focused on Brain and Mental Health (2015-2021) and Infections, Inflammations and Chronic Diseases (2015-2021), demonstrating his interdisciplinary approach. The Sharkey Lab provides a safe, inclusive, and diverse research environment that encourages open scientific exchange from diverse viewpoints. His laboratory is actively engaged in multiple collaborative projects, including investigations with UBC Okanagan on diet and probiotics targeting the gut-brain metabolic interactome, and with University of Calgary colleagues studying gut microbiota's role in ALS. Dr. Sharkey continues to advance our understanding of neural mechanisms controlling gastrointestinal function with upcoming courses scheduled for Fall 2024 and Winter 2025.

• Enteric nervous system
• Gut-brain axis
• Endocannabinoid system
• +3 more

Rolf Halden is a Professor and Center Director at Arizona State University, holding appointments in the School of Sustainable Engineering and the Built Environment, the Biodesign Center for Environmental Health Engineering, and the Global Futures Scientists and Scholars program. He is a leading expert in environmental health engineering, wastewater-based epidemiology, and bioremediation. Education: Ph.D. in Civil (Environmental) Engineering, University of Minnesota (1997) M.S. in Civil (Environmental) Engineering, University of Minnesota (1994) M.S. in Biology, Technical University of Braunschweig, Germany (1992) Postdoctoral Fellow, Environmental Science, Lawrence Livermore National Laboratory (1998) Research Focus: Halden’s research integrates environmental chemistry, public health, and sustainability to understand how anthropogenic chemicals affect ecological and human health. His lab uses advanced mass spectrometry (LC-MS/MS, MALDI-TOF) to track pollutants such as PPCPs, microplastics, pesticides, and dioxins across air, water, soil, and biological systems. He pioneered the use of wastewater treatment plants as public health observatories, enabling real-time tracking of disease, drug use, and environmental exposures. Scientific Awards & Recognition: Leadership Award, Arizona State University (2018) Rocky Mountain Emmy Award (2018) Leroy E. Burney Lecturer, Johns Hopkins School of Public Health (2011) ACS Expert Program Member (2014–present) NIEHS Superfund R01 Working Group National Leader (2012–2014) Labs & Teams: Halden is the Founding Director of the Biodesign Center for Environmental Health Engineering at ASU, where he leads a multidisciplinary team focused on environmental proteomics, bioremediation, and diagnostic tool development. He also co-leads the Human Health Observatory , a national wastewater monitoring network. Grants & Funding: Halden has secured major funding from NSF, NIH, EPA, DoD, and private industry. Notable projects include the development of in-situ groundwater monitoring devices, national wastewater surveillance of SARS-CoV-2, and studies on microplastics and neurodegenerative disease.

• Environmental Health Engineering
• Wastewater-Based Epidemiology
• Bioremediation
• +7 more

Raul Vicente Zafra is a Professor of Data Science at the University of Tartu, Faculty of Science and Technology, Institute of Computer Science, where he has been working since 2013. His research spans computational neuroscience, artificial intelligence, and data science, with a particular focus on bridging biological and artificial models of intelligence. Education: PhD in Physics (2001-2006), University of the Balearic Islands BSc in Physics (1997-2001) Professor Zafra's research interests center on computational neuroscience and artificial intelligence, with specific expertise in brain-computer interfaces, reinforcement learning, neural modeling, and explainable AI. His work bridges the gap between biological and artificial intelligence systems, exploring how neural principles can inform machine learning algorithms and vice versa. He has made significant contributions to understanding neural coherence, time interval learning in neural systems, and the application of information theory to brain-computer interfaces. His research often involves interdisciplinary collaboration between computer science, neuroscience, and medicine. Analysis of Zafra's recent publications reveals a strong focus on the intersection of artificial intelligence and neuroscience. His work spans explainable AI methods, brain-computer interfaces, reinforcement learning models that mimic cognitive processes, and neurophysiological studies of brain activity. A notable trend is his exploration of how biological principles of neural computation can inform and improve artificial intelligence systems, particularly in areas like time-based learning, consciousness modeling, and neural coherence. Scientific Awards: 2012: Attendee at the 62nd Lindau Nobel Laureate Meeting 2007: Quantum Electronics and Optics Division Prize of the European Physical Society for the best PhD Thesis in Applied Optics in Europe 2006: PhD Extraordinary Award of the Physics Department of the University of the Balearic Islands 2001: Physics Degree Extraordinary Award (First Class Honors, best GPA) 1997: Bronze Medal in the "8th Spanish Physics Olympiad" Professor Zafra has been principal investigator on numerous significant research projects including the Estonian Centre of Excellence in Artificial Intelligence, Cardiovascular Stress Impacts On Neuronal Function, and Bridging biological and artificial models of vision. His grant portfolio demonstrates strong funding support from the Estonian Research Council, European Commission, and other major funding bodies. He has supervised multiple PhD students and mentored early-career researchers in computational neuroscience and AI. His laboratory work focuses on developing computational models of neural systems and applying these insights to artificial intelligence. Current research directions include explainable AI methods, brain-computer interfaces, modeling of consciousness and cognitive processes, and the application of AI to healthcare challenges.

• Computational Neuroscience
• Artificial Intelligence
• Machine Learning
• +7 more

Zaw Myo TUN is a Research Fellow (Adjunct) at the Saw Swee Hock School of Public Health, National University of Singapore, and serves as Senior Manager (Research and Evaluation) at IRD Global Singapore. His academic career includes roles such as Postdoctoral Fellow (2022) and Research Associate (2013–2021) at the same school. He holds a PhD from NUS (2016–2021), an MSc in Epidemiology from the London School of Hygiene & Tropical Medicine (2011–2012), and an MBBS from the University of Medicine, Mandalay, Myanmar (2003–2008). His research focuses on epidemiology, global health, tuberculosis vaccines, and public health policy. Key interests include maternal vaccination coverage in low-resource settings, hospital-acquired infections (e.g., MRSA), antibiotic resistance, and the ethical implications of pandemic control measures. He has contributed to studies on SARS-CoV-2 transmission dynamics, road traffic injury patterns in Bhutan, and malaria drug policy compliance in India. His publications analyze public perceptions of health policies, such as during the COVID-19 pandemic, and explore factors influencing healthcare behaviors in diverse populations. His work bridges clinical data (e.g., electronic medical records) and population-level health surveillance to inform evidence-based interventions. While no awards are explicitly mentioned, his research has addressed critical global health challenges like tuberculosis control in Myanmar and antimicrobial stewardship in Singapore primary care settings. Zaw Myo TUN’s career emphasizes translational research, linking academic findings to real-world health system improvements. His roles span academia and non-profit sectors, reflecting a commitment to addressing public health disparities through collaborative, policy-driven solutions.

• Epidemiology
• Global Health
• Tuberculosis Vaccines
• +3 more

Vincent Quagliarello, MD, is Professor of Medicine in the Department of Infectious Diseases at Yale School of Medicine, where he also serves as Clinical Chief of Infectious Diseases and Vice Chair for Education and Academic Affairs in the Department of Internal Medicine. His research focuses on infections among older adults, with particular expertise in endocarditis, meningitis, and antimicrobial stewardship in geriatric populations. Dr. Quagliarello has been an NIH R01-funded principal investigator studying infections in older adults and received an NIH K07 Academic Leadership Award to mentor postdoctoral trainees and junior faculty. His publication record demonstrates consistent focus on antimicrobial use in elderly patients, particularly those with advanced cancer, nursing home residents, and end-of-life care scenarios. His research has significantly contributed to understanding appropriate antimicrobial therapy in geriatric populations and the management of infections in complex elderly patients. Scientific Awards: Clinical Teacher Award (2011) from Infectious Diseases Society of America Leah Lowenstein Award (2007) from Yale School of Medicine Department of Internal Medicine Teacher of the Year (1998, 1990) Laureate Award (1997) from American College of Physicians (CT Chapter) Bohmfalk Teaching Prize (1997) from Yale School of Medicine Dr. Quagliarello has served as an educational leader at Yale, directing the Internal Medicine Clerkship, the Yale Infectious Diseases Fellowship program, and creating the Department of Medicine Research in Residency Program. His clinical work spans the spectrum of infectious diseases with a special focus on public health impact.

• Infectious Diseases
• Geriatric Infectious Diseases
• Antimicrobial Stewardship
• +7 more

Associate Professor Adam Irwin is an NHMRC Emerging Leadership Fellow and Associate Professor in Infectious Diseases at the University of Queensland (UQ) and Queensland Children’s Hospital. He holds positions within the UQ Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences. His work focuses on early sepsis recognition, antimicrobial stewardship, and pediatric infectious diseases. Dr. Irwin completed his medical degree at the University of Birmingham and his PhD in 2016 from the University of Liverpool’s Institute of Infection and Global Health. He has led initiatives like the Queensland Paediatric Sepsis Program, recognized with a Global Sepsis Alliance Award and Queensland Health Excellence Awards. His research spans sepsis pathway implementation, antimicrobial resistance trends, and rapid diagnostic tools. Notable grants include NHMRC funding for studies on multi-drug resistant infections and Children’s Hospital Foundation support for genomics and antimicrobial stewardship projects. He supervises PhD candidates in areas like bloodstream infections and molecular diagnostics. Dr. Irwin collaborates across institutions, contributing to projects such as the RAPIDS Study Group and the PAEDS surveillance network. Awards include the NHMRC Emerging Leadership Fellowship and recognition for sepsis program excellence. His work emphasizes translating research into clinical practice, improving outcomes for critically ill children through evidence-based protocols and innovative diagnostics.

• Infectious Diseases
• Pediatric Medicine
• Antimicrobial Resistance
• +3 more

Alexis Battle is an Associate Professor at Johns Hopkins University with appointments in Biomedical Engineering , Computer Science , and Genetic Medicine (secondary). She directs the Malone Center for Engineering in Healthcare and serves as Deputy Director of the Data Science and AI Institute . Educated at Stanford University (PhD in Computer Science, 2013), Battle transitioned to academia after leadership roles at Google. Research Focus: Battle’s work bridges genomics and machine learning , emphasizing the impact of genetic variation on human health. Her lab develops tools like Watershed to predict functional effects of rare variants, aiming to enhance rare disease diagnosis. Key themes include non-coding DNA analysis , personalized genomics , and systems biology , with applications in cardiovascular disease and neurodegenerative disorders . Publications & Awards: Over 60 peer-reviewed articles in journals like Nature , Science , and Genome Biology , with recent emphasis on single-cell transcriptomics , multiomics integration , and telomere biology . Recipient of the President’s Frontier Award (2022), Microsoft Investigator Fellowship (2019), and Searle Scholar (2016). Scientific Awards: 2022 President’s Frontier Award 2019 Microsoft Investigator Fellowship 2019 Johns Hopkins Discovery Award 2017 Johns Hopkins Catalyst Award 2016 Searle Scholar Advising & Funding: Mentors 11 PhD students, 3 undergraduates, and postdoctoral fellows. Her research is funded by NIH, Searle Scholars, and institutional grants. The Battle Lab collaborates on projects like the GTEx Consortium , focusing on gene regulation and clinical genomics .

• Genomics
• Machine Learning
• Computational Biology
• +3 more

James B. Kaper is a Professor and Chair of the Department of Microbiology & Immunology at the University of Maryland School of Medicine. He serves as Vice Dean for Academic Affairs and previously held leadership roles as Senior Associate Dean (2014–2019) and Chair (2007–present). His research focuses on the molecular pathogenesis of diarrheagenic Escherichia coli and Vibrio cholerae , including vaccine development and bacterial-host interactions. Education: BS (1973) and PhD (1979) in Microbiology from University of Maryland; Postdoc in Molecular Pathogenesis at University of Washington (1979–1981) Dr. Kaper’s work has led to the creation of live attenuated cholera vaccines, including CVD 103-HgR, the first licensed recombinant bacterial vaccine. His lab investigates bacterial genetics, intestinal colonization, and immune system activation, particularly TLR5 response to V. cholerae flagellin. He has authored 303 peer-reviewed articles and 68 book chapters. His research has been funded continuously by NIAID since 1982. Key publications include foundational work on V. cholerae vaccines (1984), genomic structure (1998), and quorum sensing in EHEC/EPEC (1999). His lab’s recent studies focus on phosphotyrosine proteomics (2013) and pathogenicity island regulation (2007). Scientific awards: Fellow, American Academy of Microbiology (1994); NIH Merit Award (2004); ASM DC White Award (2019) Editorial roles: Editor-in-Chief, EcoSal (2006–present); Associate Editor, International Journal of Medical Microbiology (2000–present) As an academic leader, Dr. Kaper has mentored over 60 graduate students and postdoctoral fellows. He holds multiple patents for cholera vaccines and E. coli diagnostics, including U.S. Patents 4,935,364; 5,399,494; and 6,204,004. His lab at UMSOM combines basic science with translational applications for enteric disease prevention.

• Microbiology
• Immunology
• Bacterial Vaccines
• +5 more

Artur W. Dubrawski is an Alumni Research Professor of Computer Science and Director of the Auton Lab at Carnegie Mellon University's School of Computer Science. He leads interdisciplinary research on Artificial Intelligence, Machine Learning, and Robotics with real-world applications in healthcare, nuclear safety, food safety, and counter-human trafficking. His work focuses on bridging gaps between data-driven AI and empirical sciences through probabilistic modeling, predictive analytics, and time-series intelligence. Lab: Auton Lab (founded 1993) Collaborations: Allegheny County Health Department, USDA, CDC, U.S. Army Research Impact: AI for wastewater-based COVID-19 forecasting, radiological inspection systems, and hospital infection detection His students and affiliates include current PhD candidates Angela Chen, Emma Erickson, Cecilia Morales, Willa Potosnak and past researchers like Benedikt Boecking (co-inventor of Interactive Weak Supervision). The lab has spun off startups like Marinus Analytics (IBM XPrize finalists) and developed open-source tools like auton-survival for survival analysis. Key Grants: $10.5M U.S. Army contract for AI-driven predictive maintenance research.

• Artificial Intelligence
• Machine Learning
• Robotics
• +7 more

Allison Ross Eckard, MD is Professor in the Departments of Pediatrics and Medicine at the Medical University of South Carolina (MUSC) College of Medicine, serving as Division Chief for Pediatric Infectious Diseases and Director of MUSC's Ryan White Pediatric HIV Clinic and HIV Transition Clinic. She maintains an adjunct faculty position at Emory University and holds board certification in Pediatrics and Pediatric Infectious Diseases. Her primary research focuses on metabolic, cardiovascular, and nutritional complications of chronic HIV and antiretroviral therapy across age groups, with emphasis on inflammation's role in comorbidities like cardiovascular disease and bone disorders. Current investigations include NIH R01-funded research on interventions for weight gain and abdominal fat in HIV, vitamin D supplementation, and statin therapy. She has published nearly 60 peer-reviewed papers on HIV pathogenesis and treatment optimization. Dr. Eckard co-chairs the DHHS panel for Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children and serves on the DHHS panel for Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV . Her clinical work specializes in comprehensive HIV care for children through young adults, with particular focus on adolescent/young adult transition issues and global health initiatives through Lespwa Timoun in Haiti. Recent efforts include developing COVID-19 treatment guidelines for children and school safety protocols. HIV Specialist certification (American Academy of HIV Medicine) Fellow, Infectious Diseases Society of America Fellow, Pediatric Infectious Diseases Society Fellow, HIV Medical Association Member, HIV Medical Association's 'Ending the HIV Epidemic' working group She leads MUSC's HIV education initiatives and serves as inpatient consultant for pediatric infectious diseases, with advanced training in tropical medicine. Her NIH-funded research examines targeted interventions to minimize comorbidity development in HIV, while her clinical leadership spans the Ryan White HIV program, transition clinics, and global health partnerships.

• HIV-related cardiometabolic complications
• Antiretroviral therapy optimization
• Pediatric infectious diseases
• +7 more

Professor Jiyuan Tu is a Professor in the Department of Mechanical and Automotive Engineering at RMIT University's School of Engineering. He specializes in computational fluid dynamics (CFD), multiphase flows, and their applications in renewable/nuclear energy, biomedical engineering, and built environment systems. His research has led to over 500 peer-reviewed articles, 9 books, and $10M+ in ARC grants. He has supervised over 50 postgraduate students and received prestigious awards such as the RMIT Research Excellence Award (2012) and Fulbright Senior Scholar Award (2008). Research interests include CFD modelling of bioaerosol transport, drug delivery systems, and thermal energy storage. He pioneered numerical models for multiphase flows, contributing to software implementations in industries. Notable works include books on CFD and multiphase flow analysis, and leadership in international conferences like COBEE 2018. He holds honorary professorships at Tsinghua University and is Editor-in-Chief of the Experimental and Computational of Multiphase Flow journal. Industry experience includes roles at ANSTO (1996-2001). Awards span fellowships from JSPS, KOSEF, and Fulbright programs. Grants include ARC Discovery, Linkage, and LIEF projects. His work ranks him among the world’s top researchers in pebble bed reactors and airborne infection studies (SciVal 2016-2025).

• Computational Fluid Dynamics (CFD)
• Multiphase Flows
• Thermal Sciences
• +4 more

Jenna Wiens is an Associate Professor of Computer Science and Engineering at the University of Michigan's College of Engineering. She serves as Associate Director of the Artificial Intelligence Lab and co-Director of AI & Digital Health Innovation. Leading the MLD3 research group, her work focuses on machine learning and AI applications for healthcare data. PhD from MIT (2014) under John Guttag NSF CAREER Award recipient (2016) Humboldt Foundation Carl Friedrich von Siemens Award (2024) Her research addresses four key technical thrusts: Time-series analysis for predicting clinical outcomes Robust machine learning against spurious correlations Decision-making with causal inference and offline reinforcement learning Human-AI collaboration frameworks Notable methodological contributions include the FIDDLE preprocessing pipeline for clinical time-series data, foundational work on survival analysis, and novel approaches to model selection in healthcare reinforcement learning. Her work has led to real-world AI deployments in infection prevention and patient risk stratification. Scientific honors include: Forbes 30 Under 30 (2015) MIT Tech Review 35 Innovators Under 35 (2017) Sloan Research Fellowship in Computer Science (2020) Sarah Goddard Power Award (2023) Wiens collaborates with clinicians across disciplines, emphasizing clinician-in-the-loop AI systems and ethical implementation in healthcare workflows.

• Machine Learning
• Artificial Intelligence
• Healthcare Data Analytics
• +5 more

Allison Buchanan is an Associate Professor at the Dental College of Georgia , part of Augusta University . She serves as Interim Chair and Associate Chair for Oral Biology, while teaching at both predoctoral and graduate levels. Her work focuses on Cone Beam Computed Tomography (CBCT) and Digital Radiography , with a special emphasis on Quality Assurance and Obstructive Sleep Apnea imaging. Recent publications address radiation safety, disinfection methods for imaging plates, and software quality control in dental radiology. 2024 : Outstanding Faculty Award, Augusta University 2021 : Honorable mention awardee for Oral and Maxillofacial Radiology (OMR) section 2020 : Inducted into PHI KAPPA PHI Honor Society 2018 : Faculty Research and Scholarship Achievement Award Buchanan serves on multiple committees including the Standards Committee on Dental Informatics (2022-present) and the American Dental Association (2021-present), with editorial board memberships since 2018. Her teaching portfolio includes courses like Radiology Clinic II and Diagnostic Sciences Conference .

• Cone Beam Computed Tomography
• Digital Radiography
• Quality Assurance
• +2 more

Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award

• 3D Printing
• Nanotechnology
• Biomedical Engineering
• +4 more